Telomir Pharmaceuticals, Inc.
TELO· Nasdaq
TELOTelomir Pharmaceuticals, Inc.
Filed Mar 17, 2026 · 10-K · 76 days after period end · 0001493152-26-010625
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023 |
|---|---|---|---|
| Net Income | -$2.06M | -$2.90M | -$9.33M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Telomir Pharmaceuticals, Inc. · CIK 1971532 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 17, 2026 · 76 d after period end
